Download PDF
pferde spiegel 2022; 25(04): 164-170
DOI: 10.1055/a-1936-8081
Fachspiegel

EHV-1-Impfpflicht: Ein Blick auf einen Betrieb mit zwei EHV-1-Ausbrüchen

Susanne Müller
› Further Information
    Permissions and Reprints All articles of this category

Zum 1. Januar 2023 tritt die EHV-1-Impfpflicht für alle Turnierpferde in Kraft. Dabei wird die Wirksamkeit der Herpesimpfung häufig angezweifelt. Wir werfen einen Blick auf den Verlauf zweier EHV-1-Ausbrüche auf einem Betrieb, die mit 6 Jahren Abstand stattfanden.

Publication History

Article published online:
09 December 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 FN Deutsche Reiterliche Vereinigung. Warendorf FN-Press, Lagershausen H. Herpes Impfpflicht für Turnierpferde ab 2023 (23.03.2022). Accessed September 27, 2022 at: https://www.pferd-aktuell.de/news/aktuelle-meldungen/pferdehaltung/herpes-impfpflicht-fuer-turnierpferde-ab-2023
    Google Scholar
  • 2 Traub-Dargatz JL, Pelzel-McCluskey AM, Creekmore LH. et al. Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak. J Vet Intern Med 2013; 27 (02) 339-346
    CrossrefPubMedGoogle Scholar
  • 3 Marenzoni ML, De Waure C, Timoney PJ. Efficacy of vaccination against equine herpesvirus type 1 (EHV-1) infection: systematic review and meta-analysis of randomized controlled challenge trials. Equine Vet J 2022; DOI: 10.1111/evj.13870.
    CrossrefPubMedGoogle Scholar
  • 4 Foote C, Raidal Sl. Pecenpetelovska G. et al. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1. Vet Immunol Immunopathol 2006; 111(1 – 2): 97-108
    CrossrefPubMedGoogle Scholar
  • 5 Goehring LS, Wagner B, Bigbie R. et al. Control of EHV-1 viremia and nasal shedding by commercial vaccines. Vaccine 2010; 28 (32) 5203-5211
    CrossrefPubMedGoogle Scholar
  • 6 Hannant D, Jessett DM, OʼNeill T. et al. Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Res Vet Sci 1993; 54 (03) 299-305
    CrossrefPubMedGoogle Scholar
  • 7 Heldens JG, Hannant D, Cullinane AA. et al. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares. Vaccine 2001; 19 (30) 4307-4317
    CrossrefPubMedGoogle Scholar
  • 8 Bannai H, Mae N, Ode H. et al. Successful control of winter pyrexia caused by equine herpesvirus type 1 in Japanese training centers by achieving high vaccination coverage. Clin Vaccine Immunol 2014; 21: 1070-1076
    CrossrefPubMedGoogle Scholar
  • 9 Paillot R, Case R, Ross J. et al. Equine Herpes Virus-1: Virus, Immunity and Vaccines. Open Vet Sci J 2008; 2: 68-91
    CrossrefGoogle Scholar
  • 10 Pusterla N, Mapes S, Wilson WD. Use of viral loads in blood and nasopharyngeal secretions for the diagnosis of EHV-1 infection in field cases. Vet Rec 2008; 31: 728-729
    CrossrefPubMedGoogle Scholar
  • 11 Hussey GS, Giessler KS. Contribution of the immune response to the pathogenesis of equine herpesvirus-1 (EHV-1): Are there immune correlates that predict increased risk or protection from EHV-1 myeloencephalopathy?. Vet J 2022; 282: 105827
    CrossrefPubMedGoogle Scholar
  • 12 Schnabel C, Babasyan S, Rollins A. et al. An equine herpesvirus type 1 (EHV-1) Ab4 open reading frame (ORF)2 deletion mutant provides immunity and protection from EHV-1 infection and disease. J Virology 2019; DOI: 10.1128/JVI.01011-19.
    CrossrefPubMedGoogle Scholar
  • 13 StIKo Vet am FLI. http://